PSM rates did not vary by surgical technique in patients with stage pT2 cancer (PR: RR = 1.01; 95% CI, 0.63–1.63; P = 0.951; AS: RR = 0.38; 95% CI, 0.04–3.31; P = 0.382; AR + PR: RR = 1.53; 95% CI, 0.43–5.43; P = 0.511, Fig. 8B, respectively). The gene discussed is AR; the disease is cancer.